Aptose Biosciences
APTO
#10464
Rank
C$6.03 M
Marketcap
C$2.36
Share price
0.00%
Change (1 day)
735.26%
Change (1 year)

Aptose Biosciences (APTO) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : C$20.53 Million

According to Aptose Biosciences's latest financial reports the company's total liabilities are C$20.53 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aptose Biosciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$21.07 M16.9%
2022-12-31C$18.02 M70.66%
2021-12-31C$10.56 M12.77%
2020-12-31C$9.36 M9.51%
2019-12-31C$8.55 M125.17%
2018-12-31C$3.79 M71.21%
2017-12-31C$2.21 M25.29%
2016-12-31C$1.77 M-24.98%
2015-12-31C$2.36 M
2014-05-31C$2.45 M35.42%
2013-05-31C$1.81 M-32.8%
2012-05-31C$2.7 M135.46%
2011-05-31C$1.14 M-59.61%
2010-05-31C$2.84 M-82.11%
2009-05-31C$15.88 M2.83%
2008-05-31C$15.44 M8.69%
2007-05-31C$14.21 M1.28%
2006-05-31C$14.03 M-1.27%
2005-05-31C$14.21 M143.32%
2004-05-31C$5.84 M9.16%
2003-05-31C$5.35 M55.34%
2002-05-31C$3.44 M-41.47%
2001-05-31C$5.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Advaxis
ADXS
C$56.66 M 175.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
C$19.47 M-5.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
C$0.36 B 1,653.06%๐Ÿ‡บ๐Ÿ‡ธ USA